Literature DB >> 20831480

Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.

Lise Saksø Mortensen1, Simon Buus, Marianne Nordsmark, Lise Bentzen, Ole Lajord Munk, Susanne Keiding, Jens Overgaard.   

Abstract

INTRODUCTION: Polarographic oxygen-sensitive electrodes have demonstrated prognostic significance of hypoxia. However, its routine application is limited. (18)F-FMISO PET scans are a noninvasive approach, able to measure spatial and temporal changes in hypoxia. The aim of this study was to examine the association between measures of hypoxia defined by functional imaging and Eppendorf pO(2) electrodes.
MATERIALS AND METHODS: A total of 18 patients were included, nine squamous cell carcinoma of the head and neck and nine soft tissue tumors. The tumor volume was defined by CT, MRI, (18)FDG-PET or by clinical examination. The oxygenation status of the tumors was assessed using (18)F-FMISO PET imaging followed by Eppendorf pO(2) electrode measurements. Data were compared in a 'virtual voxel', resulting in individual histograms from each tumor.
RESULTS: The percentages of pO(2) ≤ 5 mmHg ranged from 9 to 94% (median 43%) for all 18 tumors. For (18)F-FMISO PET the T/M ratio ranged from 0.70 to 2.38 (median 1.13). Analyzing the virtual voxel histograms tumors could be categorized in three groups: Well oxygenated tumors with no hypoxia and concordance between the (18)F-FMISO data and the Eppendorf measurements, hypoxic tumors likewise with concordance between the two assays and inconclusive tumors with no concordance between the assays.
CONCLUSION: This study analyzed the relationship between (18)F-FMISO PET and Eppendorf pO(2) electrode measurements by use of a virtual voxel model. There was a spectrum of hypoxia among tumors that can be detected by both assays. However no correlation was observed, and in general tumors were more hypoxic based on Eppendorf pO(2) measurements as compared to (18)F-FMISO PET.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831480     DOI: 10.3109/0284186X.2010.516274

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  31 in total

Review 1.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

Review 2.  Preclinical PET tracers for the evaluation of sarcomas: understanding tumor biology.

Authors:  Ian R Sigal; Ronnie Sebro
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

3.  Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats.

Authors:  Rachel M Bartlett; Bradley J Beattie; Manoj Naryanan; Jens-Christoph Georgi; Qing Chen; Sean D Carlin; Gordon Roble; Pat B Zanzonico; Mithat Gonen; Joseph O'Donoghue; Alexander Fischer; John L Humm
Journal:  J Nucl Med       Date:  2012-08-29       Impact factor: 10.057

Review 4.  Molecular imaging of hypoxia in non-small-cell lung cancer.

Authors:  Connie Yip; Philip J Blower; Vicky Goh; David B Landau; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-21       Impact factor: 9.236

5.  Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

Authors:  Stephen R Bowen; Albert J van der Kogel; Marianne Nordsmark; Søren M Bentzen; Robert Jeraj
Journal:  Nucl Med Biol       Date:  2011-05-05       Impact factor: 2.408

Review 6.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 7.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

8.  Prognostic impacts of hypoxic markers in soft tissue sarcoma.

Authors:  Eivind Smeland; Thomas K Kilvaer; Sveinung Sorbye; Andrej Valkov; Sigve Andersen; Roy M Bremnes; Lill-Tove Busund; Tom Donnem
Journal:  Sarcoma       Date:  2012-02-20

Review 9.  Advances in radiotherapy: from 2D to 4D.

Authors:  Morten Høyer; Maria Thor; Sara Thörnqvist; Jimmi Søndergaard; Yasmin Lassen-Ramshad; Ludvig Paul Muren
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

Review 10.  Interfering with Tumor Hypoxia for Radiotherapy Optimization.

Authors:  Irma Telarovic; Roland H Wenger; Martin Pruschy
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.